JUNS

Jupiter Neurosciences, Inc. Common Stock

2.98

USD

+0.40

+15.50%

Oct 23, 15:59 UTC -4

Closed

After-Market

2.99

+0.01

+0.34%

Jupiter Neurosciences, Inc. Common Stock (JUNS) Profile

Jupiter Neurosciences, Inc. Common Stock Profile

About

Jupiter Neurosciences Inc. is a clinical-stage pharmaceutical company focused on treating neuroinflammation, with a current focus on CNS disorders and rare diseases. The Company's pipeline is focused broadly on CNS disorder and includes indications such as Alzheimer's Disease, Parkinson's Disease, Mucopolysaccharidoses Type I, Friedreich's Ataxia and MELAS. Jupiter Neurosciences Inc. is based in Jupiter, Florida.

Info & Links

CEO

Christer Ros�n

Headquarters

1001 NORTH US HWY 1, SUITE 504
JUPITER, FL 33477, UNITED STATES

Auditor

Cherry Bekaert LLP

Share holders

Employees

Jupiter Neurosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

3.94M

Enterprise Value

3.95M

Enterprise Value/EBITDA(ttm)

-0.40

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

40.87%

Operating Margin(ttm)

Profit Margin(ttm)

-5108.95%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-3148.81%

Return on Assets(ttm)

-246.66%

Income Statement

Revenue(ttm)

42.90K

Revenue Per Share(ttm)

0.06

Gross Profit(ttm)

35.40K

EBITDA(ttm)³

-9.83M

Net Income Available to Common(ttm)

-9.20M

Diluted EPS(ttm)

-19.12

Share Statistics

Beta (5Y Monthly)

1.90

52-Week Change

-97.33%

S&P 500 52-Week Change

18.83%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

770.08K

Dividend Yield

0.00%

Float⁴

561.00K

% Held by Insiders

38.60%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

1.52M

Total Cash Per Share(mrq)

1.98

Total Debt(mrq)

1.53M

Total Debt/Equity(mrq)

-417.65%

Current Ratio(mrq)

0.66%

Quick Ratio(mrq)

0.62%

Book Value Per Share(mrq)

-0.55

Cash Flow

Operating Cash Flow Per Share(ytd)

-6.68

Free Cash Flow(ytd)

-3.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.